| 1 | Energy | XLE | +50.0% |
| 2 | Technology | XLK | +31.5% |
| 3 | Healthcare | XLV | +16.4% |
| 4 | Consumer Staples | XLP | +11.9% |
| 5 | Materials | XLB | +11.6% |
| 6 | Industrials | XLI | +6.0% |
| 7 | Real Estate | XLRE | +3.9% |
| 8 | Financials | XLF | +2.0% |
| 9 | Utilities | XLU | -1.0% |
| 10 | Consumer Disc. | XLY | -2.9% |
| 11 | Communication | XLC | -12.0% |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/26 | $-1.42 | — | — | — | $0.0B | — | — | — |
| Q2 '26 | 8/6/26 | $-1.62 | $-1.50 | +7.4% | -34% | $0.0B | $0.0B | +66.0% | -57% |
| Q1 '26 | 5/5/26 | $-1.65 | $-1.67 | -1.2% | -23% | $0.0B | $0.0B | +1.3% | +1126% |
| Q4 '25 | 2/24/26 | $-1.41 | $-1.50 | -6.4% | -19% | $0.0B | $0.0B | +1.8% | +5% |
| Q3 '25 | 11/5/25 | $-1.58 | $-1.54 | +2.5% | -13% | $0.0B | $0.0B | -66.9% | +318% |
| Q2 '25 | 8/7/25 | $-1.35 | $-1.12 | +17.0% | +15% | $0.0B | $0.1B | +23.2% | +26715% |
| Q1 '25 | 5/6/25 | $-1.36 | $-1.36 | 0.0% | -2% | $0.0B | $0.0B | -39.5% | +89% |